Total Funding
20
63
Total FundingSeed raised
Growth Score
-1 pts
Heat Score
-18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
84677
Biosortia works on new drugs from deep access to the chemistry of the microbiome for immuno-oncology and immunological therapeutics.
Guy T. Carter: Chief Scientific Officer- Ross Youngs: CEO & Founder
About the Company
Biosortia Microbiomics has unique access to the hidden chemistry of the microbiome. The only capability in the world to obtain the long-sought, but previously unobtainable drug-like molecules directly from the microbiome leading to direct access of hidden molecules and filling the key missing data for artificial intelligence (AI).
